AK104 Clinical Trials
14 recruitingDrug
Phase 212Phase 13Phase 32
Showing 1–14 of 14 trials
Recruiting
Phase 2
A Phase II Clinical Study of AK104/AK112 in Combination With TT-00420 Tablet for Advanced HCC.
Hepatocellular Carcinoma (HCC)
Akeso100 enrolled1 locationNCT07052253
Recruiting
Phase 1Phase 2
A Study of AK109 and AK104 in Advanced Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma
Gastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma
Akeso138 enrolled1 locationNCT04982276
Recruiting
Phase 3
A Phase III Study of AK104 as Adjuvant Therapy in HCC With High Risk of Recurrence After Curative Resection
Hepatocellular Carcinoma
Akeso570 enrolled1 locationNCT05489289
Recruiting
Phase 2
An Exploratory, Multi-cohort Phase II Study of Combination Therapy With AK104 and AK112 for Recurrent Ovarian Cancer
Recurrent Ovarian Cancer
Akeso172 enrolled1 locationNCT06560112
Recruiting
Phase 3
A Study of AK104+Lenvatinib in Combination With Transarterial Chemoembolization (TACE) Versus TACE in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma
Hepatocellular Carcinoma
Akeso469 enrolled4 locationsNCT06371157
Recruiting
Phase 2
AK104 for Recurrent or Metastatic Vulvar Cancer
Vulvar Cancer
Akeso20 enrolled6 locationsNCT05932212
Recruiting
Phase 1Phase 2
A Study of AK104 Plus Axitinib in Advanced/Metastatic Special Pathological Subtypes of Renal Cell Carcinoma
Renal Cell CarcinomaFirst-line Treatment
Hao Zeng33 enrolled1 locationNCT05808608
Recruiting
Phase 2
A Study of AK104 With Chemotherapy as First-line Treatment in Patients With Advanced Pancreatic Cancer
Pancreatic Cancer
Akeso78 enrolled7 locationsNCT05859750
Recruiting
Phase 1Phase 2
Phase 1b/2 Study of LDRT in Combination With AK104 Plus Chemotherapy as First-line Treatment for ES-SCLC
Sichuan University57 enrolled2 locationsNCT06477523
Recruiting
Phase 2
Efficacy and Safety of AK104 Combined With Chemotherapy and Recombinant Human Adenovirus 5 Injection in Cervical Cancer
Cervical Cancer Recurrent
Fujian Cancer Hospital37 enrolled1 locationNCT06455046
Recruiting
Phase 2
AK104 With Chemotherapy as Neoadjuvant and Adjuvant Therapy for Resectable Non-small Cell Lung Cancer
Non-small Cell Lung Cancer
Henan Cancer Hospital43 enrolled1 locationNCT05377658
Recruiting
Phase 2
A Study of Concurrent Chemoradiotherapy Followed by Cadonilimab（AK104） for Newly Diagnosed Local Advanced Cervical Cancer
Cervical Cancer
West China Second University Hospital50 enrolled1 locationNCT06251388
Recruiting
Phase 2
Phase II Study on Neoadjuvant Therapy of AK104 Combined With Nab-paclitaxel/Carboplatin in Fertility Preserving Surgery
Cervical CancerNeoadjuvant ImmunotherapyFertility-sparing Surgery
Xiaohua Wu30 enrolled1 locationNCT06209294
Recruiting
Phase 2
A Study of RC48-ADC Combined With Cadonilimab（AK104）in the Treatment of HER2-expression Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Carcinoma
Shanxi Province Cancer Hospital36 enrolled2 locationsNCT06178601